A rising star involved in tumour immunity: Lactylation
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70146 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Xu Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China. Hauptthemen laut MEDLINE: Neoplasms, Tumor Microenvironment, Protein Processing, Post-Translational, Lactic Acid. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wuhu Science and Technology Program, Anhui Provincial Health Commission Provincial Financial Key Projects, Natural Science Research Project of Higher Education in Anhui Province.
Abstract (Originalsprache)
In recent years, continuous exploration worldwide has revealed that some metabolites produced during cellular and tissue metabolism can act as signalling molecules to exert different effects on the human body. These metabolites may act as cofactors for proteases or as post‐translational modifications linked to proteins. Lactate, a traditional metabolite, is found at high levels in the tumour microenvironment (TME). Many studies have shown that lactate influences tumorigenesis and development via different mechanisms, not only through the metabolic reprogramming of tumours but also through its significant impact on tumour immunity. Previously, tumour cells were reported to use glucose and glutamine to fuel lactate metabolism; however, lactate serves not only as an energy source for tumour cells but also as a precursor substance needed for the post‐translational modification of proteins. Recent studies identified a novel form of epigenetic modification, lactate‐mediated histone lysine lactylation (Kla) and demonstrated that histone lactylation directly stimulates chromatin after gene transcription; consequently, lactylation has become a popular research topic in recent years. This article focuses on the research progress and application prospects of lactylation in the context of tumour immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, The First Affiliated Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China.
- Anhui Province Key Laboratory of Non-coding RNA Basic and Clinical Transformation (Wannan Medical College), Wuhu, China.
ORCID-Profile: Xiaoxu Huang, Li Xu
Förderung
- Wuhu Science and Technology Program
- Anhui Provincial Health Commission Provincial Financial Key Projects
- Natural Science Research Project of Higher Education in Anhui Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Liang, C., Wu, C., Wan, S., Xu, L., Wang, S., Wang, J., Huang, X., & Xu, L. (2024). A rising star involved in tumour immunity: Lactylation. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70146
Vancouver
Zhang X, Liang C, Wu C, Wan S, Xu L, Wang S, et al. A rising star involved in tumour immunity: Lactylation. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70146
BibTeX
@article{Zhang2024,
author = {Zhang, Xu and Liang, Changming and Wu, Chengwei and Wan, Senlin and Xu, Lishuai and Wang, Song and Wang, Jiawei and Huang, Xiaoxu and Xu, Li},
title = {A rising star involved in tumour immunity: Lactylation},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70146}
}
EUVIMED